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Abstract
Background: High-throughput molecular biology techniques yield vast amounts of data, often by detecting small
portions of ribonucleotides corresponding to speciﬁc identiﬁers. Existing bioinformatic methodologies categorize and
compare these elements using inferred descriptive annotation given this sequence information irrespective of the
fact that it may not be representative of the identiﬁer as a whole.
Results: All annotations, no matter the granularity, can be aligned to genomic sequences and therefore annotated
by genomic intervals. We have developed AbsIDconvert, a methodology for converting between genomic identiﬁers
by ﬁrst mapping them onto a common universal coordinate system using an interval tree which is subsequently
queried for overlapping identiﬁers. AbsIDconvert has many potential uses, including gene identiﬁer conversion,
identiﬁcation of features within a genomic region, and cross-species comparisons. The utility is demonstrated in three
case studies: 1) comparative genomic study mapping plasmodium gene sequences to corresponding human and
mosquito transcriptional regions; 2) cross-species study of Incyte clone sequences; and 3) analysis of human Ensembl
transcripts mapped by Aﬀymetrix® and Agilent microarray probes. AbsIDconvert currently supports ID conversion of 53
species for a given list of input identiﬁers, genomic sequence, or genome intervals.
Conclusion: AbsIDconvert provides an eﬃcient and reliable mechanism for conversion between identiﬁer domains of
interest. The ﬂexibility of this tool allows for custom deﬁnition identiﬁer domains contingent upon the availability and
determination of a genomic mapping interval. As the genomes and the sequences for genetic elements are further
reﬁned, this tool will become increasingly useful and accurate. AbsIDconvert is freely available as a web application or
downloadable as a virtual machine at: http://bioinformatics.louisville.edu/abid/.
Keywords: Annotation, Gene ID conversion, Meta-analysis, Genomic range, Interval trees, Comparative analysis,
Granularity, Universal identiﬁer, AbsIDconvert
Background
The Nucleic Acid Research (NAR) 2012 database issue
[1] features 1,380 databases covering various aspects
of molecular biology including sequences, gene expres-
sion, structures, pathways and diseases. Most of these
databases are independent of each other and have been
created as a result of the respective developers’ domain
of interest and resource limitations. Due to a lack of
standard naming conventions, most of these databases
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prefer to assign their own custom generated identiﬁers
(IDs) to the biological entities. Major public databases
such as GenBank [2] and RefSeq [3] use accession num-
bers, Gene Ontology (GO) [4] uses a naming convention
from organism speciﬁc databases, the HUGO (Human
Genome Organization) Gene Nomenclature Committee
(HGNC) [5] uses the gene symbol and a custom gen-
erated ID, Entrez [6] uses numeric integers, sequencing
projects use systematic names and biologists sometimes
use additional aliases. As an example, the breast can-
cer early onset gene has the oﬃcial gene symbol of
BRCA2 provided by HGNC and an associated ID 1101,
Ensembl [7] gene ID ENSG00000139618, OMIM (Online
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Mendelian Inheritance in Man) [8] ID 600185, HPR
(Human Protein Reference) database [9,10] ID 02554, Ref-
Seq ID NM 000059, GenBank Accession U43746, Entrez
Gene ID 675, VEGA (the Vertebrate Genome Annotation
database) [11] gene ID OTTHUMG00000017411, UCSC
[12,13] gene ID uc001uub.1, UniProt [14] ID P51587,
and gene aliases FAD, FAD1, BRCC2, FANCD1, FACD,
FANCD.
Fortunately, there is a wealth of information available
to the research community in a wide variety of databases.
However, it is often diﬃcult to extract or integrate infor-
mation about a particular biological entity from multiple
resources. For instance, a researcher may be interested in
extracting functional information spread across diﬀerent
databases for a biological entity such as a gene or a protein;
comparing two independent pathways which use diﬀerent
types of identiﬁers; or comparing results across species,
platforms or labs. The lack of a common identiﬁer across
these heterogeneous and sometimes redundant biological
databases makes the functional analysis of biological data
tedious, time consuming, and error prone.
One solution to handle heterogeneous databases is to
use a global identiﬁer for annotations such as the one
described byMIRIAM (Minimum Information Requested
In the Annotation of biochemical Model) [15]. MIRIAM
requires a global identiﬁer to contain both the data
source as well as an internal identiﬁer. For example,
urn:miriam:hgnc:brca2 is composed of urn:miriam that
deﬁnes the notation to be a URN (Uniform Resource
Name) using the MIRIAM scheme with data type hgnc
and identiﬁer brca2. This method appears promising and
has the potential to solve some of the previously men-
tioned problems, but very few databases follow this stan-
dard. Another solution is to manually search for these
genes one by one in publicly available databases such as
Entrez, KEGG [16,17], or GEO [18,19] and infer their
functionality. This method is fruitful when the number
of genes is small, but is impractical for high throughput
experiments, where the number of gene fragments can be
on the order of tens of thousands ormore. A third solution
is to use an ID converter tool that uses a database to store
all possible annotations where a list of IDs may be input
as a query which is then converted into the corresponding
target IDs in a precise and eﬃcient way.
One diﬃculty in the development and maintenance of
such conversion tools is the varying granularity of the
identiﬁers.More speciﬁcally, the data generated by biolog-
ical experiments may be at the locus, transcript, sequence
or probe level, with varying coverage of a region of inter-
est (Figure 1). This granularity ranges from very ﬁne, at
the level of DNAmicroarrays (tens of bases in length, con-
taining probe level information relevant to only a short
region of the corresponding mRNA molecule) through
coarser granularity with sequence reads (few hundreds),
transcripts (thousands), loci, and chromosomes. It is also
possible that annotations at the same level may have dif-
ferent granularities. For example, among DNAmicroarray
probes, Aﬀymetrix® probes are usually short (25 bases)
whereas Agilent probes are longer (60 bases) and cDNA
probes are generally ≥ 500 nucleotides in length. The
Figure 1 Granularity of annotations.
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relationships between entities at the same or diﬀerent
granularities may be either 1-1, 1-n, n-1 or n-m: for
example, an Aﬀymetrix® probe may span more than one
EST; more than one such probe may be contained inside
an EST; a cDNA probe may contain zero, one or more
Aﬀymetrix® and Agilent probes.
Another diﬃculty in the development of such tools is
the dynamic nature of annotations. Of late, rapid advances
in sequencing and their declining costs have enabled
researchers to perform novel sequencing as well as rese-
quencing projects. These result in an increased depth of
coverage of a genomic sequence, with gaps being ﬁlled
and repeats more accurately mapped. Sometimes, the
sequence underlying a genetic entity may change, and
on a less frequent basis the whole genomic sequence
needs to be updated (as of August 1st , 2012, the currently
available genome versions for human, mouse and rat are
19 (GRCh37), 10 (GRCm38) and 5 (RGSC 5.0) respec-
tively). These changes may modify the structural and
functional annotations of a genetic entity (GenBank, Ref-
Seq and Ensembl are updated everyday). Frequent updates
in annotations also create problems in the manufacturing
of DNA microarrays. Microarray chips are designed and
their probes are annotated using the current build of a spe-
ciﬁc genome. Regardless of the care taken in this design,
the system will include ﬂaws due to the combination of
the delay inherent in the process of microarray design-
manufacture-deployment (compounded by the latency to
use) and the dynamic nature of annotations. Attempts to
address these problems have been the focus of a number of
previous studies. Gautlier et al. [20] found redundancies in
the annotations of Aﬀymetrix® probes at a sequence level
that map to multiple RefSeq genes. Such ambiguities may
result in inaccurate interpretations. AﬀyProbeMiner [21]
uses RefSeq and GenBank’s validated complete coding
sequences to regroup the probes on an Aﬀymetrix® chip
into consistent probe sets. In their study, regrouping of
the probes aﬀected almost 65% of the probes on the HG-
U133A chip. Harbig et al. [22] reidentiﬁed the Aﬀymetrix®
U133 plus 2.0 GeneChip® array probes in an attempt to
increase the reproducibility of microarray experiments.
They used BLAST [23] to remap the probes against the
genome and redeﬁned approximately 37% of the probes.
These studies suggest that redeﬁnition or reorganization
of probesets will improve the analytical accuracy of the
microarray data, a process that would be greatly facili-
tated by a means for high-throughput query and map-
ping/comparison of given sequences (such as microarray
probes) to other genomic annotations stored across a wide
variety of databases.
Currently available ID conversion tools
The problem of ID conversion persists even though a
number of tools exist to address this problem. Some of
these are generic and perform ID conversion for probes,
genes, proteins, and additional annotations while others
are more speciﬁc to DNA microarray probes. Organism
support varies with many of the tools catering to either
a single organism or a small set of comparable species.
In addition, cross–species comparison is variable, with
most methodologies providing only intra–species conver-
sion. Almost every approach uses some sort of relational
database with the unique identiﬁer being Ensembl IDs,
RefSeq IDs, or custom generated IDs. A brief description
of some popular tools follows.
DAVID (Database for Annotation, Visualization and
Integrated Discovery) [24-26] is a web based structural
and functional annotation tool to extract biological mean-
ing from a gene list. It uniquely generates custom IDs
for querying a set of relations and is dependent on anno-
tations from other databases. A component of DAVID,
DICT [27] (DAVID gene ID Conversion Tool), facilitates
ID conversion. EASE [28], developed by the DAVID Bioin-
formatics team, is a customizable, standalone, Windows®
desktop software application, having similar analytic capa-
bilities as that of DAVID. Babelomics [29,30] is an inte-
grated web based tool for structural and functional anno-
tation with an ID converter being one of its compo-
nents. This component uses a universal index linked to
Ensembl to create a database of 11 species. g:Convert
[31], a component of g:Proﬁler, allows arbitrary conver-
sion of genes, proteins and probes into one another. Every
alias in g:Proﬁler is mapped through a three-level index of
gene, transcript and protein Ensembl IDs. For each index
level, all corresponding IDs are stored in the database.
TheHyperlink Management System and ID Converter Sys-
tem [32] automatically updates and maintains hyperlink
information among major public biological and chemical
databases. It downloads data everyday from authorita-
tive databases and produces a large correspondence table
which is used to show the most up-to-date URL for
genes of interest. Users can use CGI programs to create
hyperlinks to this data. Synergizer [33] assigns a unique
internally generated identiﬁer, “peg”, to all external IDs
that refer to the same biological entity. It mostly uses the
NCBI “gene2accession” ﬁle to maintain a database of syn-
onym relationships and produce a simple web interface.
MADGene [34] uses correspondence tables and allows
conversions in an eﬃcient way. The Clone/Gene ID Con-
verter [35], MatchMiner [36], the Gene name converter in
GeneMerge [37], RESOURCERER [38] and GeneLynx [39]
are additional ID conversion tools.
Some of the ID conversion tools are more speciﬁc,
such as those that work only at the probe level. GATEx-
plorer [40] is a web based tool for analysis and visual-
ization of Aﬀymetrix® probes at the genomic and tran-
scriptomic level. It performs de–novo mapping of all
the probes of Aﬀymetrix®’s expression and exon arrays
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against the transcriptome of the corresponding organ-
ism using BLAST and records the coordinates on the
genome. Unmapped probes are mapped to an ncRNA
database downloaded from RNAdb. Only the perfect
match alignment is selected while mapping these probes.
The location of a gene or probe on the genome can
be visualized along with all the transcripts present in
that region. NetAﬀx™ [41], provided by Aﬀymetrix®, per-
forms ID conversion of Aﬀymetrix® probes for diﬀer-
ent organisms and has a feature to perform structural
and functional annotation. PLANdbAﬀy [42] is a Probe-
Level ANnotation database for Aﬀymetrix® microarrays
(HG-U133A, HG-U133B, HG-U133 plus 2.0, Human
Exon 1.0, Human Gene 1.0) that uses BLAT [43] to
map individual probes onto the human genome. These
probes are then annotated using information extracted
from RefSeq. ProbeMatchDB [44] uses a number of pub-
lic databases to perform cross-species and cross-platform
probe mapping. The database conversions are enabled by
UniGene and HomoloGene identiﬁers. UniProt’s [45,46]
ID mapping tool works on the gene and protein level and
converts gene IDs into UniProt IDs and vice versa.
Some software tools have unique methods for map-
ping between diﬀerent IDs. Onto–Translate [47,48] con-
verts one type of IDs into another by calculating the
optimal path between IDs, taking into account the “trust-
worthiness” of data contained in various databases. The
AliasServer [49] uses a custom generated unique 64-bit
reference identiﬁer which is computed from the amino
acid sequence using the CRC (Cyclic Redundancy Check)
algorithm where each ID is a unique combination of
species identiﬁer, type of database and the ID itself.
Some databases/tools aid in ID conversion but do not
function as a full ﬂedged ID conversion tool. BioMart
[50,51], earlier known as EnsMart [52], provides a web and
API interface to download data such as GO terms, genes,
transcripts and expression arrays from diﬀerent databases
using ﬁlters. BridgeDb [53] provides an interface to con-
nect bioinformatics tools such as Cytoscape, PathVisio,
or WikiPathways with other mapping services such as
Ensembl, PICR (Protein Identiﬁer Cross-Reference ser-
vices) [54], and any local database or text ﬁles. It is
intended to be used by bioinformatics developers and
works on the novel idea of mapping custom identiﬁers to
established identiﬁers such as Ensembl ID and then relies
on Ensembl to provide the rest of the conversion. Side by
side feature comparisons of these tools are provided in
Table 1. Data sources for select tools are listed in Table 2.
Drawbacks associated with existing approaches
Most of the ID conversion tools mentioned above use
a two step conversion method. To convert an ID “A” to
ID “B”, the ﬁrst step is to use a correspondence anno-
tation relation or table to ﬁnd a common intermediary
ID “C” (Figure 2). This common ID “C” is then con-
verted into target ID “B” using another correspondence
table. Some tools use Ensembl or RefSeq as an inter-
mediary while others generate unique custom identiﬁers.
For example, the Clone/Gene ID Converter and GATEx-
plorer use Ensembl ID, PLANdbAﬀy uses RefSeq whereas
DAVID and Synergizer use a custom generated DAVID
ID and peg respectively. These tools convert smaller frag-
ments (probes, sequences, reads) into coarser genetic
entities (Ensembl, RefSeq, EntrezID) using inferred anno-
tation level information irrespective of the fact that these
small fragments may not be representative of the anno-
tation as a whole. These methodologies also tend to lose
structural and other information available at the probe or
sequence level.
As stated previously, annotations are dynamic and
databases such as Ensembl and RefSeq are updated daily
making it diﬃcult to keep the databases of ID conversion
tools current. This is more problematic when the inter-
mediate IDs are custom generated as these require more
eﬀort to update. Most of the tools are based on a rela-
tional database and the dynamic nature of annotations
may introduce database anomalies because of the frequent
insertion, deletion and updating of the annotations. If a
gene is discovered, deleted or updated in any of these
databases, or the annotations corresponding to an entity
are added, deleted or updated, then all the databases or
correspondence tables also need to be updated. In the case
of microarray experiments, if a probe corresponds to a
recently deleted entity then that probe annotation needs
to be edited as well. Updating any of these authoritative
databases may induce a chain-reaction for any other sys-
tems using that information and any experimental result
deduced from the updated probe may become invalid.
Those tools that generate their own unique identiﬁer such
as DAVID, Synergizer or Babelomics, although eﬃcient,
face a similar situation and need to be updated frequently.
As updating an annotation database is labor and resource
intensive, some of the tools cannot aﬀord to update their
knowledgebase regularly.
Absolute (sequence based) method for ID
conversion
A feature of biological entities that is currently ignored in
ID conversion is the sequence mapping information. For
species where a reference genome is available, all nucleic
acid and protein-based annotations, no matter the gran-
ularity, can be aligned to that reference genome sequence
and therefore annotated by genomic intervals. Once the
absolute genomic coordinates on a reference genome for
all entities have been determined, these can be queried to
ﬁnd all overlapping entities, thus performing ID conver-
sion. This conversion uses the same two step method as





















Table 1 Feature comparison of diﬀerent conversion tools (As of April 2012)
Name Caters Intervals Seqs ID Annot. Linkout Query Input Output Annot. Basis of Output Organisms Availability Last
to to IDs to IDs lookup View mode conversion format update
DAVID probes, genes,     batch select one select S, F custom generated html, txt NA web,API, Sep, 2009
prots. one ⇓ EASE,
Babelomics probes, genes,   batch select one select S, F custom generated html, txt 11 org. web Sep, 2009
prots. multiple
g:Convert genes , prots. and batch select one select S, F Ensembl html, txt, xls H, M, R, O web Jun, 2011
probes one
HMS and IC genes, prots. and   batch select one select S, F corr. ﬁles html, txt H, M, O web, ⇓ current
bio. molecules one
Synergizer probes, genes and batch select one select S Peg/custom html, xls H, M, R, O web, API May, 2011
Prots. one generated
Clone/Gene genes and  batch select one select S, F Ensembl html, txt, xls H, M, R web Apr, 2008
prots. multiple
ID Converter
MADGene probes, genes,  batch NA select S, F MADGene link html, xls H, M, R, O web, open Aug, 2009
trans. multiple (17 org.) source
GATExplorer Aﬀy expression &    single probes genes, S Ensembl html H, M, R web, ⇓ Mar, 2010
exon arrays trans.
NetAﬀx™ genes, prots.,   batch select one select S, F UniGene, LocusLink html, txt H, M, R, O web CND
probes, other one
PLANdbAﬀy Aﬀy expression   single Aﬀy, Hugo,EnsAﬀy, Hugo, S RefSeq html H web, ⇓ May, 2009
arrays Ens.
probeMatchDB probes, cDNA,   batch select one select S UniGene, Homologene html H, M, R web 2006
EST, gene, prots. one
Uniprot genes and   batch genes or prots. prots. or S, F UniProt ID html NA web, API, ⇓ Jul, 2011
prots. gene
Onto- Aﬀy, uniGene clusters,  batch select one select S, F RefSeq, Entrez html, emailH, M, R, O (58 org.) web May, 2009





















Table 1 Feature comparison of diﬀerent conversion tools (As of April 2012) (Continued)
Name Caters Intervals Seqs ID Annot. Linkout Query Input Output Annot. Basis of Output Organisms Availability Last
to to IDs to IDs lookup View mode conversion format update
AliasServer Aﬀy, genes,  batch select one select multiple S custom generated html, txt Not Available Not Available CND
prots.
MatchMiner Aﬀy,  batch select one choose from S custom generated Email (txt,xls) H, M web Sep. 2006
genes
GeneMerge genes and batch select one NA S, F corr. ﬁles html 5 org. web Apr, 2007
prots.
BioMart genes, prots.,   NA select one select multiple S, F NA html, txt, xls H, M, R, O web, API, ⇓ depends on DB
probes, other
BridgeDb probes, genes, NA NA  NA NA NA S, F Ensembl, other NA 36 org. open source May, 2011
prots., metabolites
AbsIDconvert genes, trans.,      batch select one select multiple S Genomic Sequence html, txt H, M, R, O web, ⇓VM Dec, 2011
seqs., probes (53 org.)
aAbbreviations: Annot. View: Custom Annotation view, Annot.: Annotation (S: Structural annotation, F: Functional annotation), org.: Organisms (H: Human, M: Mouse, R: Rat, O: others), prots: proteins, Aﬀy: Aﬀymetrix®, trans:
transcripts, seqs: sequences, Ens.: Ensembl, corr: correspondence, acc: accession, bio: biological, NA: Not Applicable, CND: Could not determine,⇓:download Knowledgebase, VM: Virtual Machine.
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Table 2 ID converter tools, data sources and availability
Name Data Sources Webpage
DAVID GenBank, RefSeq, KEGG, OMIM, UniGene http://david.abcc.ncifcrf.gov/
Babelomics Go, KEGG, Ensembl and others http://babelomics.bioinfo.cipf.es/
g:Convert GO, KEGG, Ensembl, TRANSFAC, Reactome http://biit.cs.ut.ee/gproﬁler/
HMS and IC Ensembl, GO, KEGG and others http://biodb.jp/
Synergizer Ensembl, NCBI, RGD, SGD, KEGG, WormBase and EcoCyc http://llama.mshri.on.ca/synergizer/translate/
Clone/Gene ID Converter Ensembl, NCBI, Pubmed, UCSC, KEGG, Reactome http://idconverter.bioinfo.cnio.es/
MADGene GEO, UniGene, Entrez and others http://www.madtools.org/
GATExplorer Ensembl, Aﬀymetrix® http://bioinfow.dep.usal.es/xgate/principal.php
NetAﬀx™ NCBI, GO, KEGG and others www.aﬀymetrix.com/analysis/netaﬀx/
PLANdbAﬀy Aﬀymetrix®, UCSC, NCBI http://aﬀymetrix2.bioinf.fbb.msu.ru/
probeMatchDB UniGene, HomoloGene http://brainarray.mbni.med.umich.edu/Brainarray/
Uniprot GenBank, RefSeq, GO and others http://www.uniprot.org/
Onto-Translate Ensembl, GO, KEGG and others http://vortex.cs.wayne.edu/
AliasServer Ensembl, EMBL, NCBI, SGD and others http://cbi.labri.fr/outils/alias/
MatchMiner Aﬀymetrix®, UCSC, UniGene, Entrez, OMIM http://discover.nci.nih.gov/matchminer/index.jsp
GeneMerge GO, KEGG http://genemerge.cbcb.umd.edu/
BioMart NCBI, GO, KEGG and others http://www.biomart.org/
BridgeDb Ensembl and others http://www.bridgedb.org/
AbsIDconvert UCSC, NCBI, Ensembl, Agilent, Aﬀymetrix® and others http://bioinformatics.louisville.edu/abid/
the genomic coordinates as the basis of conversion, rather
than the annotation level information used by other tools.
Compared to other types of intermediate IDs, the inter-
vals on a reference genome sequence are relatively static,
and remapping of entities to modiﬁed genomic sequences
is relatively trivial, making it possible to easily update
the system. Using interval trees, conversion by ﬁnding
overlapping intervals is fast and eﬃcient [55].
Figure 3 shows the steps to perform sequence-based
or absolute ID conversion. In the ﬁgure, all transcripts
Figure 2 ID conversion: A two step process Step 1: ID A is
converted into ID C. Step 2: ID C is converted into ID B.
corresponding to probe A are being found. The ﬁrst step
in this conversion is to ﬁnd the genomic coordinates cor-
responding to probe A and the second step is to ﬁnd
all transcripts that span those coordinates. In this exam-
ple transcript 2 and transcript 3 are the converted IDs
corresponding to the probe A. Transcript 1 is not repre-
sented by probe A as the underlying genomic sequence is
not part of transcript 1. Subsequent sections describe the
design and implementation of a genomic interval based ID
conversion tool, AbsIDconvert.
Methods
The design of AbsIDconvert was accomplished using
a preprocessing and a query step. In the preprocess-
ing step, reference genomes were downloaded from
the UCSC Genome Browser (http://hgdownload.cse.
ucsc.edu/downloads.html) and the NCBI website. The
sequence information for a variety of identiﬁers at dif-
ferent granularities such as probes, sequences (ESTs),
transcripts and genes were downloaded from their respec-
tive authoritative websites or UCSC. The identiﬁer
types include Aﬀymetrix® probes, Agilent probes, EST
sequences, Ensembl transcripts and Entrez genes. Each
identiﬁer sequence was mapped to the respective genome
using either BLAT [43] or Bowtie [56]. BLAT was used
to map longer (>100 BP) sequences, while Bowtie was
used for relatively short (≤ 100 BP) sequences such as
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Figure 3 AbsIDconvert technique. Absolute ID conversion is a two step process whereby probe A can be converted to identiﬁers at the transcript
level by ﬁrst converting the probe to its genomic coordinates (step 1) and then determining transcripts that overlap the coordinate positions (step 2).
Aﬀymetrix® and Agilent probes. Each identiﬁer was then
annotated with structural information such as start (iden-
tiﬁer’s start coordinate on genome), end (the end coordi-
nate on the genome), size (sequence size) and chrom (cor-
responding chromosome). This information was collected
for each identiﬁer as a genomic interval. Genetic entities
with multiple exons such as transcripts were treated dif-
ferently as there are two ways in which these can be struc-
turally annotated. One method is to use the extreme ends
(i.e. start and end codons of the transcript) as their inter-
vals including both the exons as well as intronic regions, or
alternatively exclude the intronic regions and assume the
transcript’s genomic intervals are an assembly of genomic
intervals of the participating exons (AbsIDconvert incor-
porates both). Finally organism and identiﬁer type speciﬁc
interval trees were constructed and stored. A list of all
identiﬁers and their type was also stored in a relational
database to facilitate batch look-up for the types of identi-
ﬁers. Figure 4 shows the design steps of AbsIDconvert.
Once structural annotation for each of the identiﬁers is
available, AbsIDconvert can query this information. This
query step uses the structural annotation information of
each identiﬁer and the organism speciﬁc database gener-
ated from the previous step. AbsIDconvert assumes two
biological entities (nucleic acid, protein entity) are the
same if their genomic sequences are also the same, over-
lap or one is contained within the other. As the number
of annotations are large and frequent insertions and dele-
tions are routine, an eﬃcient data structure for storage
and computational operations is needed. Considering that
the structural annotation is in the form of genomic inter-
vals, a modiﬁed Red-Black tree, known as an interval tree,
is used to store the information for all IDs. An interval
tree maintains a dynamic set of elements, with each ele-
ment x containing an interval int[x]. This int[x] stores the
start and end of the interval apart from other auxiliary
information. This data structure is dynamic in nature and
can perform insertions and deletions eﬃciently in time
O(log2n), where n is the number of elements. Interval
trees have been shown to be eﬃcient for working with a
large number of genomic intervals [55].
There are four possible ways in which AbsIDconvert
may be queried:
• Lookup identiﬁers: Given a mixed list of identiﬁers,
AbsIDconvert can determine the types of identiﬁers
in the list. This step uses the relational database
created in the preprocessing step and can eﬃciently
categorize the IDs in the list.
• Batch conversion of IDs: Given a list of identiﬁers,
AbsIDconvert uses the interval tree to ﬁnd their
genomic coordinates. Once the coordinate
information is available, all overlapping identiﬁers
can be found by querying the interval tree. This uses
the IRanges [57] and GenomicRanges [58] packages
internally to maintain the genomic intervals which
are based on Allen’s Interval Algebra [59]. Users can
specify various range parameters using the interface.
The overlap type (‘type’) parameter may take any one
of ‘any’, ‘start’, ‘end’, ‘equal’ or ‘within’ as its value. By
default ‘any’ overlap is accepted. If ‘type’ value is
‘start’ or ‘end’ then the query intervals are required to
have matching ‘start’ and ‘end’ respectively with
subject intervals in the database. If ‘type’ is ‘equal’
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Figure 4 Steps involved in the construction of AbsIDconvert.
then only those subjects are retrieved which have the
exact same coordinates. For ‘within’, the query must
be contained wholly within the subject intervals.
Another parameter is for specifying the maximum
gap (‘maxgap’) between subject and query intervals to
consider them as overlapping. The default value is
zero which assumes there should not be any gap
between the subject and query intervals. This
parameter is useful for ﬁnding genes in the ﬂanking
regions of the speciﬁed intervals. The third parameter
is the minimum overlap (‘minoverlap’) size that
speciﬁes the minimum number of overlapping base
pairs needed to consider the query and subject an
overlap. The default overlap value is one. The last
parameter is the ‘select’ parameter that speciﬁes
which type of overlaps will be reported. By default, all
overlapping intervals will be reported. Selecting ‘ﬁrst’,
‘last’ and ‘arbitrary’ will report ﬁrst, last and arbitrary
overlapping intervals from the result. A simple
example using intervals is shown in Figure 5. In this
case, the reference genome is 10 BP long. The subject
database contain four intervals s1, s2, s3 and s4 that
represent the interval database. Query intervals also
consist of four intervals q1, q2, q3 qnd q4.
Considering default values for range parameters, q1
overlaps with s1, q2 and q3 overlap with all the
intervals in the subject, whereas q4 overlaps with s2,
s3 and s4. If the values of the parameters are
type=‘within’, maxgap = 0, minoverlap=1, select= ‘all’
then q1 overlaps with s1, q2 with s2 and q4 with s2
and s3. If the values of the parameters are type=‘end’,
maxgap = 1, minoverlap = 1, select= ‘all’ then q2
overlaps with s2, q3 with s3 and q4, and q4 with s2.
• Intervals as input to AbsIDconvert: A unique feature
of the ID conversion is to ﬁnd target identiﬁers
corresponding to a given interval. For example,
next-generation sequencers generally map the DNA
sequences or reads to a reference genome and output
the intervals for each aligned reads. Finding desired
target identiﬁers corresponding to these intervals is
routinely required. AbsIDconvert eﬃciently converts
these coordinates into target identiﬁers in a high
throughput manner. For instance, a user of
AbsIDconvert is able to take a set of intervals
upstream of a set of transcription start sites to
determine if any features are annotated proximal to
the regions of interest.
• Sequences as input to AbsIDconvert: Sometimes a
user may be interested in ﬁnding all identiﬁers that
correspond to a particular sequence or a list of
sequences. For instance, a user may be interested in
ﬁnding all gene names and Entrez IDs corresponding
to a set of sequences. In this case, AbsIDconvert maps
these sequences to the corresponding genome (or any
other genome for cross–species comparisons) and
determines the genomic intervals they belong to and
then retrieves all the desired target identiﬁers that
overlap these intervals. Due to the computational
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Figure 5 Example of interval overlaps. The reference region is 10 bases in length, with database annotations s1–s4. Queries q1–q4 are used to
obtain the corresponding annotations.
complexity involved in mapping long sequences
using a generic mapping algorithm such as BLAT or
BLAST, the web version of AbsIDconvert supports
only short sequence mapping using Bowtie. Longer
sequences can be mapped using BLAT in the virtual
machine version of AbsIDconvert. Sequence output
from next-generation sequencing technologies can be
catered eﬃciently using AbsIDconvert. Alternatively,
the coordinate information may be obtained by
submitting the sequences to Galaxy [60-62] or the
UCSC genome browser and subsequently inputting
the intervals using AbsIDconvert. Mapping
parameters can be speciﬁed by the user through the
interface. Parameters include the maximum number
of mismatches which can range from zero (default) to
three. The second mapping parameter speciﬁes
which type of alignments are to be reported. The
default value is ‘all Best’ in which all best alignments
will be reported by Bowtie. However, ‘all’, ‘k’ or ‘k
Best’ can be selected for Bowtie output.
AbsIDconvert also has another parameter ‘Do not
report (..more)’ that takes a positive integer value
which speciﬁes that Bowtie will suppress all
alignments for a particular read if the total number of
reportable alignments for that read is more than the
speciﬁed value. The default value of -1 speciﬁes that
all alignments will be accepted. For instance, if this
value is set to 100, then Bowtie will suppress all those
alignments for reads that map to 100 or more
locations on the genome. This is an eﬀective option
to mask repeat sequences or small sequences from
appearing into the output because their probability to
map at multiple locations on the genome is higher.
AbsIDconvert supports 53 major species for performing
ID conversion on a list of identiﬁers and a list of intervals.
It also has sequence level mapping support for 12 major
species including Homo sapiens, Mus musculus, Rattus
norvegicus, Bos taurus, Gallus gallus, Sus scrofa, Xenopus
tropicalis, Anopheles gambiae, Drosophila melanogaster,
Caenorhabditis elegans, Saccharomyces cerevisiae, and
Danio rerio. AbsIDconvert converts the input (intervals,
IDs and sequences) into target identiﬁers with links to
authoritative databases. All intermediate interval ﬁles
are available to download for later use. It also generates
custom annotation ﬁles that can be used to view the IDs
simultaneously (chromosome–wise) as a custom track in
the UCSCGenome Browser. The performance and poten-
tial uses for AbsIDconvert are discussed in the following
sections.
Results and discussion
Intervals vs. relational database
The genomic coordinate information for diﬀerent identi-
ﬁer types mapped to 53 species were stored as intervals.
An interval tree method was implemented and used to
store and query the corresponding interval information
for each identiﬁer type. For comparison with relational
databases, an equivalent MySQL database was imple-
mented to perform ID conversion based on coordinate
information, and the run time for both of these methods
were compared.
Run–time comparisons of the interval tree and MySQL
implementations were performed using randomly sam-
pled rat EST IDs which were subsequently converted to
Entrez gene IDs. To test the actual runtime, the number
of EST IDs was increased exponentially for each test point
and the corresponding execution time (in seconds) was
measured. The run time complexity of the interval tree
maintained a constant rate while the relational methodol-
ogy grows in linear fashion, allowing for the conversion of
millions of identiﬁers in only a few seconds (Figure 6).
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Figure 6 Runtime comparison betweenMySQL and interval-tree approach while converting EST IDs into Entrez Gene IDs.
Further analysis of conversion runtime was performed
using 1,000 random sampled IDs from Aﬀymetrix®
Rat230 2 microarray probes, Agilent Cgh105a microar-
ray probes, RefSeq IDs, Ensembl transcripts, Entrez genes,
HUGO gene symbols and EST IDs which were converted
into one another using the web version of AbsIDcon-
vert (Table 3). The extreme left column represents the
source identiﬁers which are converted to target identi-
ﬁers shown in ﬁrst row. The numbers in small parentheses
in the ﬁrst row show the total number of genomic coor-
dinates for individual ID types (for instance, Aﬀymetrix®
Rat230 2.0 probes have altogether 231,971 intervals
stored). Since AbsIDconvert supports conversion to mul-
tiple target types, the last column represents the time
elapsed when an input type is converted into all other
ID types.
Run–time comparison
Direct comparison to other ID conversion approaches is
not straightforward due to the diﬀerences in annotation
information (based on the last available update), sup-
ported ID types, and development/deployment platforms.
In order to test the runtime of comparable solutions
(DAVID, Clone/Gene ID Converter, GATExplorer, MAD-
Gene, and AbsIDconvert), a varying number (100 to
30,000) of Aﬀymetrix® Rat230 2.0 microarray probesets
were converted to Entrez IDs (Figure 7). When the num-
ber of probe sets converted was small (100), the conver-
sion time for all tools was nominal. For a moderate num-
ber of probe sets (5,000) MADGene, DAVID and AbsID-
convert performed similarly (12.6, 6.1 and 5.1 sec. respec-
tively), while GATExplorer took around a minute and
Clone/Gene ID Converter took 15 minutes (Figure 7(a)).
Table 3 Run time (sec.) to convert 1,000 IDs from one type to another using web–based AbsIDconvert
Rat230 2 Cgh105a RefSeq EnsTrans Entrez gene GeneSymbol EST seq All
(231,971) (97,973) (160,644) (349,445) (30,972) (30,972) (3,918,403)
Aﬀymetrix Rat230 2 5.6 3.2 4.1 7.6 3.2 3.3 33 47.6
Agilent Cgh105a 5.1 3.9 2.5 2.7 2.92 3.05 31.3 55.6
RefSeq 4.5 3.1 3.6 3.6 2.3 2.2 31.9 34.5
Ensembl transcript 2.9 3.8 3.1 4 2.47 3.02 34.6 47.1
Entrez gene 2.7 2.9 2.8 3 7.5 7.1 18.4 35.3
Gene symbol 2.9 2.8 2.7 2.9 8.5 7.5 16.6 38.2
EST sequences 18.6 17.6 31 30.3 28.3 29.3 64.1 73.7
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Figure 7 Runtime comparison of AbsIDconvert with other conversion tools. (a) Tools give comparative run times with a small input (i.e.
≤ 5, 000). (b) The number of inputs was gradually increased to 100,000 and run times for each tool were determined. Most of the tools were not able
to produce the result for large inputs. Only MADGene and AbsIDconvert could produce results. Note that DAVID limits user input to 30,000 identiﬁers.
As the number of probe sets further increased, all of the
tools, with the exception of MADGene and AbsIDcon-
vert, were incapable of tractably handling such a large
number of inputs. Since the Aﬀymetrix® Rat230 2.0 has
roughly 31,000 unique probe sets and over 300,000 indi-
vidual perfect match probes, a run time comparison for a
large number of inputs (> 30, 000) was performed by con-
verting randomly sampled human transcripts into Entrez
IDs (direct conversion of individual probes is not possible
within all of the tools; therefore the closest comparison
is made to the same number of human transcripts). For
100,000 inputs, only MADGene and AbsIDconvert com-
pleted successfully, taking 45 sec and 24 sec, respectively
(Figure 7(b)). The run–time complexity for AbsIDconvert
compares favorably to other similar tools, demonstrating
its applicability in the analysis of high throughput data.
Output accuracy
The accuracy of conversions performed using AbsID-
convert was assessed based on the overlap of the suc-
cessfully converted IDs with those found using other
tools for three types of conversions. In the ﬁrst conver-
sion, 1,000 unique Entrez IDs were randomly sampled
from the “org.Hs.eg.db” Bioconductor annotation package
and converted to their corresponding oﬃcial gene sym-
bols. Ten ID conversion tools, from a total of 19 tools
listed in Table 1, can perform this conversion. Consider-
ing NCBI as the authority for Entrez IDs, the accuracy
of diﬀerent conversion tools were evaluated using the
following assumptions:
1. NCBI contains the most up to date information and
its annotations are correct.
2. An Entrez ID may be annotated by more than one
gene symbol.
3. Given an Entrez ID x, if a tool converts x to a set of
gene symbols, Y (x → Y ), and NCBI annotates x to
another set of gene symbols, Z (x → Z), then
accuracy terms can be deﬁned as:
• True positives (TP) are those conversions in
which the converted gene symbol set contains
all the gene symbol(s) annotated by NCBI (i.e.
Z ⊆ Y ).
• False positives (FP) are unexpected results.
This includes incorrect conversions (Z  Y ), as
well as those conversions in which NCBI does
not annotate an Entrez ID with any gene symbol,
but a tool ﬁnds some gene symbol corresponding
to that Entrez ID (Z = φ and Y = φ).
• False negatives (FN) are missing conversions
in which a tool could not ﬁnd corresponding
gene symbol(s) (Z = φ and Y = φ).
• True negatives (TN) are the correct absence of
conversion in which NCBI as well as a particular
tool does not convert an Entrez to any gene
symbol (Z = φ and Y = φ).
4. Accuracy is deﬁned as
%Accuracy(ACC) = TP + TNTP + TN + FP + FN ×100
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Table 4 shows the contingency table and associated
statistics for the conversion of 1,000 Entrez IDs to gene
symbols. AbsIDconvert converted a total of 885 Entrez
IDs with an accuracy of 87.2% followed by DAVID (853,
79.1%), MADGene (854, 73.1%) and HMS & IC (724,
72.9%). Although Onto-Translate converted a total of 823
Entrez IDs, it has more FP conversions than HMS & IC
and therefore a lower accuracy. We further investigated
the conversions from the top four tools on the basis of
their accuracy and summarized the results in a Venn dia-
gram (Figure 8(a)). AbsIDconvert converted a total of 83
Entrez IDs which are missed by the other tools. NCBI
places all these Entrez IDs onto the reference genome and
annotates them with gene symbols that are in agreement
with AbsIDconvert (Additional ﬁle 1). Of these 83 Entrez
IDs, 48 are categorized as “pseudo”, 27 as “miscRNA”, four
as “protein-coding”, three as “unknown” and one as “other”.
AbsIDconvert was unable to convert a total of 115 Entrez
IDs, out of which 21 IDs were not converted by any of the
tools examined.
Of the 94 Entrez IDs that AbsIDconvert was not able to
convert but other tools were (Additional ﬁle 2), most were
either “not on current assembly”, meaning that the refer-
ence sequence for that Entrez ID could not be mapped
to the current genome (28 IDs), but could be mapped to
previous genome assemblies; or “not annotated on ref-
erence assembly”, indicating that the sequence cannot be
found on the reference assembly at all (61 IDs). Five con-
versions were found where the Entrez IDs reported had
since been deleted and replaced (DAVID and MADGene
both converted these IDs).
In a second conversion test, 1,000 randomly sampled
Entrez IDs were converted to RefSeq IDs using ten of
the 19 tools listed in Table 1 (the others are not able to
perform this type of conversion and were not evaluated).
There are many diﬀerent classes of RefSeq IDs, includ-
ing mRNA (ID starts with NM ), RNA (NR ), protein
(NP ), as well as predicted versions of each one (XM ,
XR and XP respectively). How RefSeq IDs are segregated
for conversion diﬀers among the tools tested. For exam-
ple, a number of tools combine all the diﬀerent types of
RefSeq IDs into one converted ID type while others treat
each one separately. Other tools ignore the predicted Ref-
Seq IDs and only consider mRNA and RNA. For example,
AbsIDconvert’s RefSeq database combines both mRNA
and RNA, whereas MADGene includes predicted prod-
ucts (XM). DAVID and Synergizer have separate options
for RNA and mRNA RefSeq. Therefore, to enable com-
parison between all the tools, only those conversions that
result in mRNA or RNA RefSeq IDs are considered, and
for those tools that report them separately, the results
from both conversions were combined. In addition, any
predicted RefSeq IDs (i.e. those that begin with X) were
removed.
Using the same assumptions as reported for the Entrez
to Symbol conversion, the accuracy of conversion for each
tool was calculated (Table 5). Of the 1,000 Entrez IDs used,
NCBI annotates only 599 with one or more RefSeq. In this
case, the accuracy for the various tools ranged from a high
of 75.6% (AbsIDconvert) to a low of 38.9% (HMS & ID).
The results from the four most accurate tools were
investigated further. 497 Entrez IDs were converted com-
monly by all tools (Figure 8(b)). AbsIDconvert converted
586, followed by MADGene (551), DAVID (549) and
Onto-Translate (501). Five conversions speciﬁc to MAD-
Gene were not found by AbsIDconvert (Additional ﬁle 3).
In this case, AbsIDconvert correctly mapped the Entrez
IDs to the genome (Additional ﬁle 4); however, the cor-
responding RefSeq IDs were not in the data obtained
from UCSC. Other conversions that AbsIDconvert did
not report were found to be false positives reported by
other tools. For example, DAVID andOnto-Translate both
reported converting “4586” to “NM 017511” and “441956”
to “NM 001013729”; however, the genomic intervals for
those IDs do not overlap, and both RefSeq IDs are shown
in NCBI as “permanently suppressed”. For the twenty
Table 4 Entrez ID to gene symbol conversion accuracy
Tool totalMapped TP FP FN TN TPR FPR ACC FDR F1 score
AbsIDconvert 885 866 19 109 6 88.82 76.00 87.20 2.15 93.12
DAVID 853 790 63 146 1 84.40 98.44 79.10 7.39 88.32
MADGene 854 730 124 145 1 83.43 99.20 73.10 14.52 84.44
HMS & IC 724 723 1 270 6 72.81 14.29 72.90 0.14 84.22
Onto-Translate 823 722 101 176 1 80.40 99.02 72.30 12.27 83.90
MatchMiner 539 457 82 458 3 49.95 96.47 46.00 15.21 62.86
Clone/Gene ID converter 537 441 96 457 6 49.11 94.12 44.70 17.88 61.46
g:Convert 445 433 12 549 6 44.09 66.67 43.90 2.70 60.69
Synergizer 445 433 12 549 6 44.09 66.67 43.90 2.70 60.69
Babelomics 486 421 65 508 6 45.32 91.55 42.70 13.37 59.51
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Figure 8 Venn diagram showing conversion results for the top performing conversion tools. (a) Entrez IDs converted to oﬃcial gene
symbols. (b) Entrez IDs converted to RefSeq IDs. (c) Entrez IDs converted to RefSeq IDs using cumulative bootstrap. (d) Aﬀymetrix® HG U133Plus2.0
probesets converted to Agilent Cgh44b probes.
conversions speciﬁc to DAVID, the reported RefSeq IDs
were found to be associated with diﬀerent Entrez IDs in
NCBI (Additional ﬁle 5).
The thirty-eight Entrez IDs converted only by AbsID-
convert were investigated further to verify whether they
were “correct”. Thirty-three are in agreement with the
NCBI data (Additional ﬁle 6). For the other ﬁve, we exam-
ined the genomic intervals of both the Entrez IDs and
reported RefSeq IDs to verify that they do indeed overlap
(intervals are reported in Additional ﬁle 7). In all cases the
converted IDs do have overlapping intervals with two of
the Entrez IDs discontinued and replaced since the initial
construction of the AbsIDconvert database, “100505905”
(to “23189” on March 2, 2012) and “100652874” (to
“100505641” on Feb 3, 2012).
To better assess the accuracy of AbsIDconvert com-
pared to other tools, the Entrez to RefSeq ID conver-
sion was repeated ten times, randomly choosing 1,000
Entrez IDs each time. Out of the 10,000 randomly
selected Entrez IDs, 8,974 were unique. AbsIDconvert
Table 5 Entrez ID to RefSeq ID conversion accuracy
Tool Total Mapped TP FP FN TN TPR FPR ACC FDR F1 score
AbsIDconvert 586 362 224 20 394 94.76 36.25 75.60 38.23 74.79
MADGene 551 335 216 49 400 87.24 35.06 73.50 39.20 71.66
Onto-Translate 501 291 210 99 400 74.62 34.43 69.10 41.92 65.32
DAVID 549 311 238 72 379 81.20 38.57 69.00 43.35 66.74
Synergizer 482 278 204 121 397 69.67 33.94 67.50 42.32 63.11
g:Convert 482 278 204 121 397 69.67 33.94 67.50 42.32 63.11
MatchMiner 474 268 206 126 400 68.02 33.99 66.80 43.46 61.75
Babelomics 501 267 234 128 371 67.59 38.68 63.80 46.71 59.60
Clone/Gene ID converter 421 219 202 195 384 52.90 34.47 60.30 47.98 52.46
HMS & ID 461 227 430 181 162 55.64 72.64 38.90 65.45 42.63
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converted 5,700 (63%), followed by MADGene (5,343,
59.5%), DAVID (5,254, 58.5%) and Onto-Translate (4,786,
53.3%) (Figure 8(c)). A total of 945 (10%) of the IDs were
exclusively converted by AbsIDconvert.
In the third conversion, 1,000 randomly sampled human
Aﬀymetrix® GeneChip HG-U133 Plus 2.0 probesets were
converted to Agilent Cgh44b probes (Figure 8(d)). This
type of cross-platform conversion is important in meta-
analysis studies where results are drawn by integrating
and analyzing data from a number of independent stud-
ies/platforms. As this type of conversion is available only
in Synergizer, we compared the conversion results of
this tool with AbsIDconvert. Synergizer converted 183
whereas AbsIDconvert converted 162 probesets. The rea-
son for the small number of conversions is primarily due
to the design diﬀerences of the probes on these chips.
Two questions required deeper investigation: 1. Why was
AbsIDconvert not able to convert 64 Aﬀymetrix® IDs that
were successfully converted by Synergizer; and 2. Are
the 43 conversions exclusive to AbsIDconvert valid? To
answer these, we extracted the design annotation of all the
Aﬀymetrix® GeneChip HG-U133 Plus 2.0 probesets pro-
vided by Aﬀymetrix’s NetAﬀx [63] along with the design
annotations for the Agilent Cgh44b probes supplied by
Agilent [64]. These provided the individual locations of
each probe on the hg19 genome, thereby enabling investi-
gation of the interval separation between the probesets.
In order to examine the 64 probesets converted by
Synergizer but not by AbsIDconvert, the genomic loca-
tion(s) of the Aﬀymetrix® probesets were compared to the
genomic locations of the Agilent probes. Fifty-six (out of
64) of the probes are separated according to their genomic
locations and do not overlap at all. This separation ranges
from 75 to 418,671 BP with a median separation of 4,736
bases. Further analysis determines that these all lie in the
regions between the individual probes of the respective
probesets and therefore have no shared sequence identity.
Most of the ID converter tools including Synergizer map
the genetic entities (probes, probesets) spanning tens of
bases to an intermediary such as Ensembl that is at a
coarser granularity spanning a few kilobases with possi-
ble intronic regions. While performing conversions, these
tools only use the probe annotation, disregarding the
actual sequence information. The above false positives
provided by Synergizer are likely the result of ignoring
the sequence level information as the two types of probes
actually span diﬀerent genomic intervals.
Next we considered conversions found exclusively by
AbsIDconvert. Based on the oﬃcial annotation from
NetAﬀx™, we found that intervals for all 43 Aﬀymetrix®
probesets actually contain or overlap the converted Agi-
lent probes with a mean overlap of 56.43 bases. Con-
sidering that most of the Agilent probes are 60 bases
long and an Aﬀymetrix® probeset contains overlapping
25 bp probes, this indicates most of these Agilent probes
are contained in the Aﬀymetrix® probeset region. These
probesets were checked at the probe level and it was deter-
mined that these converted Agilent probes overlap with
individual Aﬀymetrix® probes to some extent, or are com-
pletely contained with a mean overlap length of 38.70 BP.
We are not sure why Synergizer was unable to convert
these 43 probes; however, the oﬃcial annotation con-
ﬁrms these annotations and bolsters our conﬁdence in the
power and accuracy of our sequence based ID conversion.
Case studies
Three illustrative case studies were explored to demon-
strate the capabilities of AbsIDconvert. The ﬁrst case
study considers sequence-based mapping of identiﬁers in
a comparative genomics analysis of organisms involved
in malaria; the second examines remapping of probes to
annotations within and across species using a histori-
cal cDNA platform from Incyte; and the third identiﬁes
Ensembl transcripts mapped by Agilent and Aﬀymetrix®
arrays.
Case study 1: Comparative genomics: plasmodium
mapped to human and Anopheles gambiae
Recent studies have surveyed the role of both host
and pathogen genetic variability to determine molecu-
lar signatures for host-pathogen interactions [65]. While
the interactions between a pathogen and its host are
often mediated by the host immune system responses
to the pathogen, host-pathogen relationships theoretically
have the potential to create a metagenomic environment
whereby the total transcriptome is contributed by both
the host and pathogen genes. In some cases, such as Neis-
seria meningitidis, a direct interaction between host and
pathogen genes has been demonstrated [66]. As an illus-
trative example, it might be possible that shared sequence
similarities between pathogen and host genes play a role
in host gene regulation via pathogen genes and gene
products that provide additional promoter sites, miRNA
targets, and binding motifs similar to those found in the
host. To test the feasibility of this possibility in the con-
text of malaria, we used absIDConvert to identify coding
sequences identical between the Plasmodium falciparum
(PF) and Plasmodium vivax (PV) species and the human
and anopheles genomes.
Plasmodium is a parasite responsible for causing
malaria in humans primarily in tropical and sub–tropical
areas. About 3.3 billion people are at risk of this dis-
ease, leading to 250 million malaria cases and one mil-
lion deaths worldwide every year (http://www.who.int/
features/factﬁles/malaria/). Altogether four Plasmodium
species are responsible which are carried by the female
Anopheles gambiae mosquito. PF and PV are the most
common, with PF being the deadliest.
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Coding sequences for each gene for these two
species were downloaded from the PlasmoDB website
(http://plasmodb.org/) [67]. The total number of coding
sequences in PF and PV were 5,524 and 5,435 respec-
tively. Sequences for each of these genes were then frag-
mented into 50 base-pair (BP) long sequences with an
overlap of 25 BP. The fragmented sequences were given
a unique name by attaching a numerical suﬃx onto the
gene name that denotes the order of appearance in the
gene sequence. These fragmented sequences were ana-
lyzed using AbsIDconvert by selecting default parameters
including no mismatch while aligning to the Anopheles
gambiae (AnoGam2) and Homo sapiens (hg19) genomes
(Figure 9).
A total of 75 gene fragments from PF (PF Hg19 in
Figure 9(a)) had an exact sequence match to 692 human
genes (PF Hg19 in Figure 9(b)). For PV, the aligned
number of gene fragments and corresponding genes
were 17 (PV Hg19 in Figure 9(a)) and 340 (PV Hg19
in Figure 9(b)), respectively. These numbers indicate
that the gene fragments align to multiple locations on
the human genome. Among genes that were mapped
from PF and PV gene fragments, a total of 134 genes
were common. When the same gene fragment sequences
from PF and PV were aligned to the Anopheles gam-
biae genome (AnoGam2), a total of 99 (PF AnoGam2 in
Figure 9(a)) gene fragments from PF were mapped to 87
(PF AnoGam2 in Figure 9(b)) diﬀerent genes, showing
that the correspondence between the gene fragments and
genes is largely one–to–one. These numbers for PV were
12 (PV AnoGam2 in Figure 9(a)) and 31 (PV AnoGam2 in
Figure 9(b)), respectively.
A more detailed analysis of the genes identiﬁed using
ontological information indicates a signiﬁcant enrichment
in cell adhesion processes (Table 6). These are present in
the GO terms ‘cell-cell adhesion’ (and others), but also
implied by the large number of terms regarding neuronal
axonogenesis and synapse formation, which require spe-
ciﬁc regulation of cellular adhesion. While purely specu-
lative at this point, it is possible these plasmodium genes
interact with the human host to help sequester human
erythrocytes in small blood vessels which aids in the inva-
sion plasmodium into the immune system [68]. While
benchtop analysis of these genes is needed to determine
if the “feasible” actually occurs, it is clear that analysis
using AbsIDconvert has identiﬁed, via cross-species anal-
ysis, a limited set of genes that can be further interrogated
for understanding the malaria-related pathophysiology,
including the process of plasmodium incorporation into
erythrocytes.
Case study 2: Reinterpretation of prior datasets
Annotations used for DNA microarray studies quickly
become out–of–date as more knowledge emerges about
a species’ transcriptome. In addition, there are instances
where one microarray platform may be used to measure
gene products from a comparative species. For example,
Incyte arrays spotted with human ESTs have been used to
query gene expression levels in mouse and/or rat, based
on the assumption that the human ESTs would bind to
and provide measurements of the corresponding gene in
rodents [69-71]. Using the original EST sequences spotted
on the array from these studies, we sought to verify the
current annotations of the ESTs, and also determine which
rodent genes should bind the ESTs based on sequence
alignment to the human, mouse, and rat genomes. Orig-
inal EST sequences were found by searching two sources
using the Incyte IDs supplied on the chip. The ﬁrst source
was the NCBI EST database, using a search string com-
posed of “IMAGE:” and the Incyte clone ID number
(identiﬁes clones generated from the IMAGE consor-
tium sequencing project). The second source was the
Open Biosystems database (http://www.openbiosystems.
com/), using a search string composed of “LIFESEQ” and
Figure 9 Case study 1 - Comparative genomics study using AbsIDconvert. (a) Venn diagram showing the number of gene fragments from P.
falciparum (PF) and P. vivax (PV) which overlaps with at least one gene from Anopheles gambiae and Homo sapiens. (b) Corresponding genes in
Anopheles gambiae (AnoGam2) and Homo sapiens (hg19) that were mapped by gene fragments from P. falciparum and P. vivax. Only those genes
were considered which had the exact same sequence as the gene fragments.
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Table 6 Signiﬁcantly enriched (p-value< 0.001, number of genes≥ 2) Gene Ontology biological processes for the P.
falciparum and P. vivax genes
GO ID Description listMembership pFal.Pvalue pViv.Pvalue
GO:0048639 positive regulation of developmental growth pFal 0.00023 0.078421
GO:0051865 protein autoubiquitination pFal 0.000611 0.310842
GO:0007417 central nervous system development pFal 0.000749 0.052751
GO:0010559 regulation of glycoprotein biosynthetic process pFal 0.000534 0.189699
GO:0043062 extracellular structure organization pFal 0.000896 0.056366
GO:0031290 retinal ganglion cell axon guidance pFal 0.000729 0.020543
GO:0050772 positive regulation of axonogenesis pFal 0.000671 0.108078
GO:0007268 synaptic transmission pFal 9.63E-005 0.004437
GO:0007156 homophilic cell adhesion pFal 2.90E-005 0.00181
GO:0048745 smooth muscle tissue development pFal 0.00097 0.215514
GO:0008038 neuron recognition pFal,pViv 0.000611 2.71E-005
GO:0071702 organic substance transport pViv 0.358064 0.000932
GO:0010827 regulation of glucose transport pViv 0.15634 0.000705
GO:0016337 cell-cell adhesion pViv 0.002316 0.000615
GO:0045725 positive regulation of glycogen biosynthetic process pViv 0.316458 0.000806
GO:0008037 cell recognition pViv 0.041274 0.000425
GO:0010907 positive regulation of glucose metabolic process pViv 0.486254 0.000312
GO:0045913 positive regulation of carbohydrate metabolic process pViv 0.561654 0.000731
GO:0010676 positive regulation of cellular carbohydrate metabolic process pViv 0.561654 0.000731
GO:0030036 actin cytoskeleton organization pViv 0.133792 8.55E-005
GO:0030029 actin ﬁlament-based process pViv 0.099308 2.74E-005
the clone ID number. In some instances, multiple EST
sequences were returned for each clone ID. A total of
8,392 sequences were downloaded and aligned to the
genomes of human, rat, and mouse using AbsIDconvert
with the default BLAT settings. The genome wide best
alignment was found for each probe by considering only
those alignments falling within 5% of the maximal align-
ment score (Figure 10(a)). Corresponding to each of these
aligned coordinates, overlapping Entrez IDs were found
for all three organisms. Out of the 7,095 human Incyte IDs
which had corresponding genomic interval(s), 4,155 have
at least one human Entrez ID associated with them. This
number was 2,081 (out of 3,368) for mouse and 1,438 (out
of 2,776) for rat (Figure 10(b)).
Homologous genes can be compared across species
using NCBI’s Homologene resource [72] when gene
names are known. However, if sequence information is
available, it would be best to use that sequence informa-
Figure 10 Case study 2 - Reinterpretation of prior datasets using AbsIDconvert. (a) Number of Incyte IDs (from a total of 8,392) mapping to the
human, mouse and rat genomes within 5% of the maximum alignment score. (b) Incyte IDs with at least one Entrez ID found using AbsIDconvert.
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Table 7 Comparison of Homologene and sequence based homologs
Organism mapped† Entrez ‡ Homol§ Human (Hom) Mouse (Hom) Rat (Hom) Human (Seq) Mouse (Seq) Rat (Seq)
Human 7095 4155 3854 – 3648 (88%) 3401 (82%) – 1002 (24%) 806 (19%)
Mouse 3368 2081 1872 1794 (86%) – 1715 (82%) 1002 (48%) – 1064 (51%)
Rat 2776 1438 1263 1210 (84%) 1222 (85%) – 806 (56%) 1064 (74%) –
amapped†:Number of probes mapped to Genome; Entrez‡:Mapped probes with Entrez ID; Homol§: Probes with Entrez ID as well as Homologene ID; Hom:
Homologene Based Homologs; Seq: Sequence Based Homologs determined using AbsIDconvert.
tion to determine if homology exists based on sequence
conservation, particularly in cases where probes of known
sequence are being used to measure a speciﬁc gene, such
as in DNA microarrays or in–situ hybridization. Both
methodologies were applied to the Incyte array used in
[69-71].
For the Homologene based comparison, all of the Incyte
IDs that map to at least one Entrez ID using AbsIDcon-
vert were used to determine if a homologous gene exists,
and if so, if there are corresponding entries for each of the
species studied. Similarly, for those Incyte probes match-
ing at least one Entrez ID, the sequence was used as a
query into each of the other species using AbsIDconvert
to determine if the probe maps to and overlaps an Entrez
ID in a cross-species sense. As Table 7 indicates, using
the Homologene conversion alone yields a high number of
homologs (82% – 88%); however, using the sequence level
information, it can be seen that a much lower percent-
age of probes (19% – 74%) actually map to known Entrez
gene regions in the other species. These demonstrate that
only a small number of the probes on the array should be
utilized for cross species comparisons.
Case study 3: Meta–analytic studies across platforms
Meta-analysis enables the integration of many diﬀerent
experiments with a common research hypothesis. How-
ever, high-throughput -omics meta-analyses are hindered
due to the heterogeneity of DNAmicroarray array designs
(length and location of probes), data acquisition, analy-
sis, and inter- and intra-study variability. Therefore, many
meta-analyses use the same species or even the same
array platform to mitigate some of these heterogeneities.
However, many studies do still attempt to perform cross-
platform and inter-species meta-analyses, and tools such
as AILUN (Array Information Library Universal Nav-
igator) [73], A-MADMAN (Annotation-based microar-
ray data meta-analysis tool) [74], and LOLA (List Of
Lists Annotated) [75] enable cross-species meta-analysis
using Entrez ID, gene symbol or other IDs as a con-
version intermediary. AbsIDconvert can perform cross-
platform/-species analysis eﬃciently using the sequence
based approach.We previously demonstrated that AbsID-
convert eﬃciently and accurately converted Aﬀymetrix®
HG U133Plus2.0 probes into Agilent Cgh105a probes,
among other types of conversions.
To determine how comparable two microarray stud-
ies using diﬀerent array platforms on a common organ-
ism could be, Aﬀymetrix® HG U133Plus2.0 and Agilent
Cgh105a probe sequences were mapped and converted
to corresponding human Ensembl transcripts using the
default AbsIDconvert parameters. For the Aﬀymetrix
platform, 423,815 out of 603,158 probes were mapped to
one or more transcripts, with 94,713 of the total Ensembl
transcripts (173,742) being mapped (Figure 11). This
leaves 79,029 Ensembl transcripts that were not mapped
by any Aﬀymetrix® probes. For Agilent, 27,184 (out of
99,026) mapped to 60,829 Ensembl transcripts. 79,029
(45% of the total) Ensembl transcripts do not have any
mapped Agilent Cgh105a probes. The number of shared
Ensembl transcripts between platforms was surprisingly
small (46,308), indicating that each platform appears to
have probe speciﬁc subsets of Ensembl transcripts. The
number of Ensembl transcripts not probed by either plat-
form was surprisingly large. This appears to be due to
a lack of probes designed to bind those Ensembl tran-
scripts, as the majority of unmapped transcripts are much
Figure 11 Case study 3 - Cross-platformmeta-analysis study
using AbsIDconvert. Ensembl transcripts mapped by Agilent Cgh
105a (purple) and Aﬀymetrix® HG U133Plus2.0 (green) probes.
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shorter than those that are mapped (Additional ﬁle 8). As
Figure 11 illustrates, 46,308 transcripts should be directly
comparable between Aﬀymetrix® HG U133Plus2.0 and
Agilent Cgh105a, while a large number of transcripts are
not available in one or the other (or both) platforms.
Conclusion
AbsIDconvert is the only known gene ID conversion tool
based on genomic coordinates/intervals of which we are
aware. This is a novel and important contribution in the
realm of gene ID conversion due to the large variety of
genetic entities in current use by biologists, the need
to convert between them, and the fact that most bio-
logical entities (nucleic acid, protein entities etc.) have
an associated sequence. Mapping of the entity sequence
to a reference genome sequence provides the concomi-
tant genomic interval that allows determination of other
entities that have overlapping genomic intervals.
The interval basis of AbsIDconvert provides ease of ﬂex-
ibility with respect to any additions, deletions or updates
of the underlying objects, requiring only adding of inter-
vals, removing intervals, or modifying the intervals them-
selves, respectively. This makes it possible to easily keep
the structure updated as the current state of biological
knowledge changes. Amajor update is only required when
the underlying genome changes, a fairly rare occurrence
for most organisms, especially when compared to how
often other genomic databases are modiﬁed.
These intervals also allow easy discovery of genetic enti-
ties that only partially overlap with queried IDs/intervals,
or that are within a speciﬁed distance nearby. More fre-
quently, researchers are interested in those genes that are
near speciﬁc genomic intervals corresponding to various
types of genetic control elements such as transcription
factor binding sites, enhancers, untranslated regions, and
hyper/hypo methylated regions. AbsIDconvert makes it
easy to ﬁnd those entities that overlap or lie nearby regions
of interest. With the incorporation of a sequence mapping
algorithm, AbsIDconvert integrates the determination of
genomic intervals for any supplied sequence, making it
possible to easily ﬁnd and convert between IDs from any
platform and organism, such as the examination of corre-
spondence of the human EST clones with rat and mouse
genes (case study 2) and of plasmodium and human genes
(case study 1). We do not know of any other system that
can easily accomplish these types of analyses.
AbsIDconvert can greatly facilitate the work of those
who are involved in meta analyses studies. When com-
paring studies where either the species and / or platform
varies, this methodology will have clear advantages over
others as it is based on common genomic coordinates.
The use of an interval tree structure makes it possible
to perform large conversions quickly and eﬃciently. This
method is eﬃcient while dealing with genomic intervals
and has a signiﬁcant advantage over other methods such
as relational databases. Although theoretically limited by
working memory, none of the interval trees generated and
used by AbsIDconvert require more than 300MB of RAM
on the deployed server, with the majority being rather
small in size (less than 10 MB). If the data cannot ﬁt into
main memory, a method such as that proposed by Arge et
al. [76,77] can be used that maintains the interval tree in
secondary memory eﬃciently.
AbsIDconvert is provided as a web page at http://
bioinformatics.louisville.edu/abid/, and is also available as
a virtual machine for those wishing to run a local instance.
Future work will include providing command line access,
a RESTful interface, and modifying the interface to uti-
lize a workﬂow management tool for genomic data such
as GALAXY, where the primary data units are genomic
sequences and intervals.
Additional ﬁles
Additional ﬁle 1: Table containing the NCBI Entrez gene symbol and the
AbsIDconvert detected gene symbols for 83 Entrez IDs uniquely converted
by AbsIDconvert.
Additional ﬁle 2: Table containing information on the Entrez ID, gene
symbol, gene type, and NCBI annotation for the 94 Entrez IDs converted by
one or more conversion tools missed by AbsIDconvert.
Additional ﬁle 3: Table containing information on the Entrez ID, RefSeq
ID, and conversion results for Entrez IDs correctly converted to RefSeq IDs
by MADGene that are missed by AbsIDconvert.
Additional ﬁle 4: Table containing information on the chromosomal
positions found for the ﬁve Entrez IDs that AbsIDconvert is unable to
successfully convert to RefSeq IDs.
Additional ﬁle 5: Table containing information on the Entrez IDs
converted to RefSeq IDs by DAVID that do not have NCBI annotated RefSeq
entries.
Additional ﬁle 6: Table containing information on the 38 Entrez IDs
converted exclusively by AbsIDconvert to RefSeq IDs. Thirty-ﬁve of the
Entrez IDs are in agreement with NCBI’s Entrez annotation.
Additional ﬁle 7: Table containing interval and overlapping RefSeq
information for the ﬁve Entrez IDs converted exclusively by AbsIDconvert
to RefSeq IDs that are not annotated in NCBI Entrez.
Additional ﬁle 8: Figure showing the distribution of Ensembl transcript
lengths for those transcripts either mapped or unmapped by either/both
Aﬀymetrix®HG U133Plus2.0 and Agilent Cgh105a microarray probes.
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